Weight-Loss Drugs Could Boost US Economy by Billions, Goldman Sachs Forecasts
• More widespread use of weight-loss drugs like Ozempic could boost US GDP by up to 1% ($360 billion) over the next decade by improving health and increasing the labor supply (Goldman Sachs forecast)
• Poor health limits economic growth by reducing available workers and hours worked due to missed workdays, early deaths, and caregiving
• Up to 70 million Americans could be taking weight-loss drugs by 2028 - resulting in lower obesity rates and positive spillovers to the broader economy
• If 30 million Americans took these drugs, economy would grow 0.4%; if 60 million took them, economy would grow 1%
• Historically, health advancements have increased GDP by lowering lost life years from disease/disability by 10% per decade